Clinical trial · Interventional
Acupuncture for Breast Cancer Related Lymphedema
Effectiveness of Acupuncture for Breast Cancer Related Lymphedema Patients: a Multicenter, Randomized, Sham-controlled Clinical Trial
NCT04158193CI-TRIAL-00041540unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the clinical efficacy of acupuncture on chronic upper limb lymphedema in patients with breast cancer surgery
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Lymphedema | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| acupuncture | Other | — | UNRESOLVED |
| sham acupuncture | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Acupuncture group
- description
- Subjects in the acupuncture group are given acupuncture treatment.
- interventionNames
- Other: acupuncture
- type
- EXPERIMENTAL
- label
- Sham acupuncture control group
- description
- Subjects in the sham acupuncture control group are given non-acupoint shallow acupuncture.
- interventionNames
- Other: sham acupuncture
Primary outcomes (1)
- measure
- Upper extremities volume
- timeFrame
- 7 weeks
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * At least 6 months after breast cancer surgery and presents with persistent breast cancer related upper extremity lymphedema for at least 3 months. * Stage II lymphedema according to the 2016 consensus by the international society of lymphology. * Women aged 18 to 80 years * Out-patients * Estimated life expectancy \> 6 months * Upper extremity lymphedema is defined a more than 10% volume difference between the affected and unaffected arms Exclusion Criteria: * Bilateral breast cancer related lymphedema * Tumor metastasis or recurrent patient * Patients who is undergoing chemotherapy, radiation therapy or targeted therapy * Taking diuretic * Upper extremity lymphedema reached more than 80% volume difference between the affected and unaffected arms * History of primary lymphedema * A diagnosis of severe heart, liver, kidney or hematologic disease * Edema caused by upper extremity disability or other conditions such as heart failure, kidney disease or malnutrition * Have hypoproteinemia * Inflammation, scar, or trauma at the site of operation, or other active skin infections * Unable to self-care, had a history of psychological disorders, or unable to communicate * Received lymphedema treatment within the past 1 month * Pregnancy or breastfeeding * The presence of electronic medical device implants * Deny to sign the informed written consent, or unwilling to conform to randomization * Participation in other clinical trials during the study period
References
Publications (0)
Data not yet available
No reference posted for this study.